Dudediligence.

Theravance Biopharma Inc

TBPHNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$16.9MSep ’24$18.8MDec ’24$15.4MMar ’25$26.2MJun ’25$20.0MSep ’25$45.9MDec ’25$17.7MMar ’26$20.7MJun ’26
Net income, by quarter
−$12.7MSep ’24−$15.5MDec ’24−$13.6MMar ’25$54.8MJun ’25$3.6MSep ’25$61.0MDec ’25−$4.9MMar ’26−$5.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$55.3M$51.3M$57.4M$64.4M$107.5M
Operating income−$257.8M−$92.0M−$56.0M−$46.9M−$3.6M
Net income−$199.4M$872.1M−$55.2M−$56.4M$105.9M
Operating cash flow−$207.9M−$187.0M−$27.0M−$11.5M$238.5M
Free cash flow−$211.3M−$187.6M−$29.5M−$11.9M$238.5M
Cash$90.0M$298.2M$39.5M$37.8M$167.8M
Debt$616.3Mnone on file$0.00none on filenone on file
Shares outstanding74.4M65.2M48.1M49.5M51.1M